Ischemia induces early changes to cytoskeletal and contractile proteins in diseased human myocardium  by Hein, Stefan et al.
ISCHEMIA INDUCES EARLY 
CHANGES TO 
CYTOSKELETAL AND 
CONTRACTILE PROTEINS IN 
DISEASED HUMAN 
MYOCARDIUM 
Ischemia is known to produce damage to subcellular organelles, such as 
nuclei and mitochondria, in myocardial tissue. We tested the hypothesis 
that during myocardial ischemia various cytoskeletal and contractile 
proteins also undergo changes. We induced total global ischemia by 
incubation in buffer of tissue samples from six human left ventricles that 
were obtained from heart transplant recipients. Samples were removed 
from the incubation medium at different ime intervals and investigated by 
immunohistochemistry using monoclonal antibodies against myosin, actin, 
tropomyosin, troponin T, myomesin, desmin, tubulin, and vinculin. The 
degree of ischemic injury was determined by electron microscopy. Ischemic 
cardiomyopathic human tissue showed disturbances of the localization 
pattern of myosin, actin, tropomyosin, and troponin T as early as 10 
minutes after the onset of ischemia; this disruption was complete at 20 
minutes. Tubulin also started changing at 10 minutes, but complete 
disruption was only evident after 120 minutes. Desmin and myomesin 
showed an intermediate r sponse; changes began at 30 to 40 minutes, and 
disruption was complete at 90 to 120 minutes. Vinculin was most resistant 
to ischemia. Ultrastructurally, the tissue showed moderate reversible 
ischemic injury during the entire period of 180 minutes. Measuring the 
exposure time in seconds allowed quantitation of the intensity of the 
fluorescence. We reached the following conclusions: (1) Ischemia causes 
damage to the contractile proteins sooner than to the cytoskeleton and 
subceIlular organelles. (2) Diseased human hearts are extremely suscepti- 
ble to the effects of ischemia. These findings are important for the situation 
of induced cardiac arrest in heart operations and for preservation ofdonor 
hearts for transplantation. (J THORAC CARDIOVASC SURG 1995;110:89-98) 
Stefan Hein, MD, Thomas Scheffold, MD, and Jutta Schaper, MD, PhD, 
Bad Nauheim, Germany 
T he effects of ischemia on animal and human myocardium have been extensively studied dur- 
ing the last three decades by means of functional 
methods, biochemical methods and electron micros- 
copy. 1-6 Our own previous studies were mainly con- 
cerned with the ultrastructural changes in reversible 
and irreversible types of injury. 1 Our findings pro- 
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vided criteria for the evaluation of the quality of 
cardioprotection during heart operations. 
Electron microscopy can estimate structural 
changes occurring in mitochondria, nuclei, or the 
T-tubular system. It can also estimate the degree of 
disorganization of the myofilaments. Finer defects 
in molecular structure of the contractile apparatus, 
however, cannot be detected in this way. Further- 
more, many components of the contractile machin- 
ery and the cytoskeleton cannot be seen at all by 
electron microscopy because they lack contrast and 
specific morphologic definition. Other microscopic 
methods are therefore needed to study morphologic 
signs of injury of the various cardiac muscle pro- 
teins. Immunohistochemistry allows the microscopic 
visualization of proteins with the aid of specific 
antibodies. This visualization helps to detect early 
changes in localization and integrity of these mole- 
cules. 
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Table I. List of primary antibodies 
Antibodies Clone Source Antigen 
Actin HHF-35 DAKO-Corporation. c~ and 3, Skeletal, heart, and smooth muscle actin 
Phalloidin-fluorescein 
isothiocyanate 
Tropomyosin 
Tropomyosin 
Troponin T 
Myosin 
Myosin (head) 
Myosin (tail) 
Tubulin 
Desmin 
Myomesin 
Vinculin 
Carpiuteria, Calif. 
Amersham. Buckinghamshire, 
U.K 
CH1 Sigma. Deisenhofen. Germany 
TM 311 Sigma, Deisenhofen. Germany 
JLT 12 Sigma. Deisenhofen. Germany 
CCM 52 Gift* 
3 E 4 Gift* 
4 F 5 Gift+ 
DM-1-A Sigma. Deisenhofen. Germany 
Tub-2.1 Sigma. Deisenhofen. Germany 
DE-U-10 Sigma. Deisenhofen, Germany 
B 4 Gifts 
Vc 11-5 Sigma. Deisenhofen. Germany 
From Amanita phalloides 
Chicken muscle tropom~)osin 
Smooth muscle tropomyosin from chicken gizzard 
Skeletal muscle troponin T from rabbit 
Chicken embryo heart, myosin heavy-chain 
Human heart, myosin heavy-chain 
Human heart, myosin heavy-chain 
a-Microtubulin from chicken brain 
/3-Microtubulin from rat brain 
Desmin from pig stomach 
Myomesin from Cultured cells 
Smooth muscle vinculin from chicken gizzard 
*Gift of Prof. Dr. R. Decker. Chicago. Ill. 
+Gift of Prof. Dr. H. Katus, Heidelberg, Germany. 
:~Gift of Prof. Dr. M. Eppenberger-Eberhardt. Zfirich. Switzerland. 
Our  aim in this study was to investigate ischemic 
human myocardium for possible early changes in the 
contracti le and cytoskeletal proteins. It  will be 
shown that these proteins undergo degenerat ive 
alterat ions ooner than do subcellular organelles. 
Myosin and the thin f i lament complex seem to be 
extremely susceptible to the effects of ischemia, 
whereas the components of  the Wtoskeleton have a 
higher ischemic tolerance. 
Methods and material 
Human myocardium. Cardiac tissues from explanted 
hearts from six patients who were undergoing cardiac 
transplantation, four of whom had dilated cardiomyopa- 
thy and two of whom had coronary artery disease, were 
investigated in this study. All patients had New York 
Heart Association stage IV conditions and an ejection 
fraction of less than 20%. Several left ventricular myocar- 
dial samples from each heart were immediately frozen in 
liquid nitrogen. These were used as "zero time" control 
tissues. The remaining tissues were used for experiments. 
The remaining explanted heart tissues were incubated 
in a humid chamber at 20 ~ C for 30, 60, 90, 120, and 180 
minutes. Four to six samples per heart and per time 
interval were removed from the container and frozen in 
liquid nitrogen. A total of about 20 to 25 tissue pieces 
from each heart were investigated. In addition, at each 
time interval small samples (about 1 mm long and 0.5 to 
1.0 mm thick) from each heart were fixed for electron 
microscopy in cold 3% glutaraldehyde buffered with 1 
mol/L sodium cacodylate. 
Immunohistochemistry. Cryostat sections 4 /xm in 
thickness were fixed with 4% paraformaldehyde at room 
temperature. They were first stained with hematoxylin and 
eosin for evaluation of the state of tissue preservation and 
selection of longitudinal s,ections. Sections cut transver- 
sally or diagonally were reembedded to a longitudinal 
orientation. Antibodies against myosin, actin, tropomyo- 
sin, troponin T, and myomesin were used to detect the 
contractile proteins. Antibodies to desmin, tubulin, and 
vinculin were used to detect he proteins associated with 
the cytoskeleton. The first antibodies are listed in Table I. 
The detection system was biotinylated onkey antimouse 
immunoglobulin 1:50 (Amersham International Ltd., Lit- 
tle Chalfont, U.K.), followed by fluoreseein isothiocya- 
hate-labeled streptavidin ata dilution of 1:50. Nuclei were 
stained with 0.0001% propidium iodide according to the 
modified protocol from Jones and Kniss 7. The sections 
were viewed in a Leitz Aristoplan (Leitz, Wetzlar, Ger- 
many) or Olympus Vanox T (Olympus Optical Co. 
Ltd., London, U.K.) light microscope quipped with fluo- 
rescence filters. Micrographs were taken on Kodak pro- 
fessional 200 ASA color slide film (Eastman Kodak 
Company, Rochester, N.Y.). All micrographs are repro- 
ductions from color slides that are representative of all 
fields examined. Immunohistochemical results were as- 
sessed in several ways: (1) qualitative stimation of the 
localization of different antibodies, (2) determination of
the time at which the first changes in localization and 
pattern were observed and the time when the changes 
were maximal, and (3) measurement of the intensity of 
fluorescent labeling according to the photographic expo- 
sure time (in seconds) in the microscope. For these 
measurements, glass slides were prepared with control 
(nonischemic) and ischemic tissue to standardize the 
exposure times measured. All sections from the entire 
experiment were stained for a given antibody at the same 
time. Care was also taken to avoid photobleaching and 
quenching. Ten randomly selected areas of each section 
were measured, for a total of at least 100 areas per animal. 
Spot measurements were used. 
Controls. Control tissue consisted of "zero time" 
nonischemic human myocardium. Several further control 
systems were used in this study. Normal porcine myocar- 
dium was used in place of nonischemic human myocar- 
dium to compare localization of the antibodies. Myocytes 
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Table I I .  Effects of ischemia on contractile and cytoskeletal proteins in the human heart 
5 10 20 30 40 50 60 90 120 150 180 
Protein rain rain rain rain rain rnin rain min rain rain rain 
Actin (HHF 35) 0 B F F F F F F F F F 
Phalloidin-fluorescein isothiocyanate 0 B F F F F F F F F F 
Tropomyosin (CH1) 0 B F F F F F F F F F 
Tropomyosin (311) 0 B F F F F F F F F F 
Troponin T 0 B F F F F F F F F F 
Myosin (CCM 52) 0 B F F F F F F F F F 
Myosin (3 E 4) 0 B F F F F F F F F F 
Myosin (4 F 5) 0 B F F F F F F F F F 
Tubulin (c~ + /3) 0 B I I I I I I F F F 
Desmin 0 0 0 B I I I F F F F 
Myomesin 0 0 0 0 B I I I F F F 
Vinculin 0 0 0 0 0 0 B I I I I 
EM n n rev I I I I I I I rev 
O, No alteration; B, beginning of alterations; F, fully expressed alterations;/, 
ischemic injury. 
isolated by collagenase perfusion of normal rat hearts 
were also tested. Several first antibodies from different 
sources were used, to exclude the possibility that the 
changes observed were caused by the specific staining 
properties of one particular antibody (Table I). The first 
antibody was omitted to check for nonspecific staining. In 
cases of strong nonspecific staining, another second anti- 
body was tested until the reaction was optimal. All 
reactions on control and ischemic tissues were carried out 
simultaneously to eliminate variations in labeling inten- 
sity. 
Electron microscopy. All samples were immersion fixed 
in 3% buffered glutaraldehyde, postfixed in osmium te- 
troxide, rinsed in buffer, dehydrated in a graded series of 
alcohol and propylen oxide, and embedded in Epon (Ladd 
Research Inc., Burlington, Vt.). Semithin sections were 
stained with toluidin blue, viewed in the light microscope 
for artefact free areas and ultrathin 50 nm sections were 
prepared. These were stained with uranyl acetate and lead 
citrate and viewed in a Phflips EM 201 electron micro- 
scope (Philips, Eindhoven, The Netherlands). All micro- 
graphs were evaluated for the degree of ischemic injury 
according to a semiquantitative scoring system, 1 and these 
data were compared with the results from immunohisto- 
chemical studies. 
Western blotting and immunoblots. The frozen tissue 
samples were homogenized in extraction buffer (0.1 mol/L 
tromethamine-hydrochloride pH 8.0, 10% Sodium dode- 
cyl sulfate, 10 mmol/L ethylenediamine tetraacetic acid, 
40 mmol/L dithiothreitol), heated and centrifuged. The 
supernatant was diluted with the extraction buffer to 10 
mg/ml and 60% glycerin and 0.05% bromophenol blue 
were added. F romeach sample, a 5 ~1 portion was 
analyzed in a 12.5% sodium dodecyl sulfate polyacryl- 
amide gel. 
In Western blotting experiments, the proteins were 
transferred from the gel to a nitrocellulose membrane (0.2 
fLm; Schleicher & Schucll GmbH, Dassel, Germany) with 
0.8 mA/cm 2 for 60 minutes. The membrane was treated 
with 5% nonfat milk powder to block nonspecific binding. 
The antibodies for vinculin, desmin, myosin; troponin T, 
actin, tropomyosin, and tubulin were the same as those 
increase instructural damage; EM, electron microscopy; n, normal; rev, reversible 
used in immunohistochemical tests (Table I). They were 
used in dilutions ranging from 1:50 to 1:500 in 2% 
phosphate-buffered saline solution. Goat-antimouse im- 
munoglobulin labeled with peroxidase was applied as 
secondary antibody in a dilution of 1:50 (Boehringer 
Mannheim GMBH, Mannheim, Germany). Multiple 
washing steps after each incubation were included in the 
protocol. Binding of the antibody was detected by means 
of 4-chloro-l-naphthol and water in triethanolamine 
buffer. A specific-molecular weight marker (broad range; 
BioRad, Mfinchen, Germany) was stained with colloidal 
go ld  (BioRad). 
Results 
Electron microscopy. For  the evaluation of the 
degree of ischemic injury, we used our semiquanti-  
tative evaluation system as previously descr ibedJ  
Reversible injury is character ized by an increasing 
clearing of  the mitochondr ia l  matr ix and fragmen- 
tat ion of the cristae. Nuclei  show clearing and 
clumping of the chromatin. Reversible injury can be 
light, moderate,  or severe, depending on the degree 
of progression of the mitochondr ia l  and nuclear 
changes. Irreversible injury is character ized by the 
occurrence in the mitochondr ia  of amorphous,  
dense areas consisting of  calcium and l ipoprotein 
deposits. Al l  control  tissues had a normal  ultrastruc- 
tural  appearance.  In human ischemic myocardium, 
there was light but reversible ischemic injury at 20 
minutes. At  the end of the experiment,  we found 
moderate  but still reversible injury. Al l  ultrastruc- 
tural data are l isted in Table II, which also describes 
the immunohistochemical  results. 
Immunohistoehemistry measurements 
Qualitative evaluation of the labeling pattern. In 
human, pig, and rat nonischemie tissue, most of the 
antibodies produced a distinct cross-striation pat- 
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tern. Appearance varied, depending on the type of 
protein characterized. In ischemic Samples, the cross 
striations were attenuated (beginning of the alter- 
ations, B). Later, they disappeared completely (fully 
developed isturbance of the antibody localization, 
F). This localization pattern was similar for all 
species investigated. The time points for the begin- 
ning and completion of alteration are listed in Table 
II. There were no differences between human hearts 
with dilated cardiomyopathy and those with isch- 
emic heart disease. 
Myosin. Myosin was located exclusively in the 
A-band in nonischemic human myocardium. This 
location gave the appearance of small quadrangles 
of constant length, independent of the state of 
contraction (Fig. 1, a). Ten minutes after the onset 
of ischemia, the cross striation pattern in the human 
hearts was not homogeneous and had partially dis- 
appeared (Fig. 1, b). At 20 minutes and subsequent 
time intervals, the localization of the myosin anti- 
body  was completely diffuse and cross striations 
were absent (Fig. 1, c). In Fig. 1 (d) the negative 
control preparation obtained by omission of the first 
antibody is shown. Specific staining is absent. 
Actin. The three components of the thin filament 
complex, actin-tropomyosin-troponin T, showed a 
similar tolerance to ischemia. Illustrations are there- 
fore given only for troponin T. These are represen- 
tative for the entire complex. Actin labeling by 
phalloidin, the specific antibody, or  both, showed 
early changes in ischemic tissue (beginning at 10 
minutes) and the appearance of the fully developed 
pattern of changes at 20 minutes. 
Tropomyosin. Staining for tropomyosin in non- 
ischemic cardiomyocytes was seen as fine cross 
striation corresponding to that of actin. Both anti- 
bodies stained both isoforms, and this resulted in a 
homogeneous labeling pattern. Ischemia produced 
early changes at 10 minutes, and the fully developed 
changes were observed at 20 minutes and all subse- 
quent time intervals. 
Troponin T. Troponin T showed a labeling pattern 
similar to that of actin (Fig. 2, a). The early changes 
Fig. 1. Staining for myosin (green fluorescence), a, 
Nonischemic human myocardium shows a regular cross 
striation for myosin, b, Partial loss of the cross striation at
10 minutes of ischemia, c, Total loss of the specific 
labeling at 20 minutes of ischemia, d, Negative control 
with omission of the first antibody shows absence of 
specific green fluorescence. Yellow dots are lipofuscin 
granules. Nuclei are stained red. 
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Fig. 2. Staining for troponin T (green fluorescence), a In 
nonischemic myocardium, the cross striation pattern is 
regular and intercalated disks remain unstained (arrows). 
b, Complete absence of a regular cross striation at 20 
minutes of ischemia. Nuclei are stained red. 
occurred at 10 minutes after ischemia, and the fully 
developed changes were seen at 20 minutes (Fig: 2, b). 
Tubulin. Tubulin filaments are rather coarse (25 
nm in diameter) and run in the longitudinal axis of 
the myocyte in an irregular network (Fig. 3, a). Isch- 
emia caused partial disappearance of the filamentous 
staining pattern at 10 minutes (Fig. 3, b). The fully 
developed changes were only observed at 120 minutes 
(Fig. 3, c). 
Desmin. A clear cross striation pattern was seen 
with the desmin antibody in nonischemic myocar- 
dium from all species (Fig. 4, a). Desmin reacted to 
ischemia t later time points than did the contractile 
filaments. Disappearance of the distinct cross stria- 
tion pattern started at 30 minutes (Fig. 4, b), and the 
fully developed pattern of changes occurred at 90 
minutes (Fig. 4, c). 
Myomesin. Myomesin was localized close to the 
M-band as a distinct fine line (Fig. 5, a). In human 
Fig. 3. Tubulin staining (green fluorescence), a In non- 
ischemic myocardium, the staining is intense but not homo- 
geneous, mostly in thelongitudinal direction of the cells, b, 
At 10 minutes of ischemia, the staining is less intense and 
extremely irregular, c, Complete disturbance of the labeling 
pattern at 120 minutes. Nuclei are stained red. 
hearts, myomesin showed amoderate sensitivity to the 
effects of ischemia. The beginning of changes occurred 
at 40 minutes (Fig. 5, b), and the fully developed 
changes were seen at 120 minutes (Fig. 5, c). 
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Fig. 4. Desmin staining (green fluorescence) in human 
myocardiu m. a, Nonischernic myocardium shows a regular 
cross striation but also lack of desmin (arrows) and 
accumulation i other areas (arrowheads). b, At 30 min- 
utes of ischemia, the cross striation pattern is disturbed. 
Intercalated disks are clearly labeled (arrow). c, Complete 
disappearance of the cross striation pattern at 90 minutes 
of ischemia. Nuclei are stained red. 
Fig. 5. Myomesin staining (green fluorescence), a, In 
nonischemic human myocardium, a regular cross striation 
pattern can be observed. The dark spaces between cells 
correspond with extracellular fibrotic material, b, Distur- 
bance of the cross striation at 40 minutes of ischemia, c, 
At 120 minutes of ischemia, the cross striation pattern is 
totally disturbed. Nuclei are stained red. 
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Vinculin. Vinculin was localized in the interca- 
lated disk and in the lateral sarcolemma in all 
species (Fig. 6, a). Vinculin was resistant o the 
effects of ischemia. The beginning of changes ap- 
peared as late as 60 minutes after the onset of 
ischemia (Fig. 6, b), and fully completed changes 
were not seen during the entire course of the 
experiment. 
Measurements of the intensity offluorescence. As 
described in the Methods and Material section, the 
intensity of the fluorescent light emitted by the 
labeled sections was measured in the microscope as 
time in seconds needed for an optimal photographic 
exposure. The data presented in Fig. 7 show that 
exposure times needed increased with longer isch- 
emic periods. These data are in agreement with the 
results from Table II that describe the alterations in 
localization of antibodies. The contractile proteins 
showing early qualitative Changes exhibited a more 
pronounced loss of fluorescence intensity than did 
proteins such as myomesin, desmin, and especially 
vinculin, which changed much later. 
Western  blots. The results are shown in Fig. 8. 
The bands for the different proteins were similar at 
all time intervals and were identical in appearance 
to those in control preparations. They were, how- 
ever, thinner at later time points. This thinning 
indicates that the amount of protein was reduced. 
Bands of proteins of lower molecular weight were 
not observed. 
Discussion 
In this study, we showed that the contractile 
proteins are more sensitive to the effects of ischemia 
than are the components of the cytoskeleton. Vin- 
culin is the most resistant of all the proteins inves- 
tigated. Damage to the proteins occurred uring the 
reversible phase of injury, as determined by electron 
microscopy. 
Methodology. The model of in vitro ischemia has 
been shown to be suitable for the investigation of 
the in vivo 8' 9 effects of ischemia. Herdson, Kalten- 
bach, and Jennings 1~ compared myocardial ischemia 
in vitro with that observed in vivo and concluded 
that the results obtained with the two models are 
comparable. Grochowski and colleagues 11and Ar- 
miger and coworkers 12 confirmed this observation. 
The results presented here therefore apply to the in 
vivo situation of global ischemia as used in heart 
operations. 
Measurements of fluorescence. An excellent 
agreement was found between the qualitative val- 
Fig. 6. Vinculin staining (green fluorescence), a, In 
nonischemic myocardium, vinculin is localized at the 
intercalated disks and the lateral sarcolemma, b Slight 
reduction of the staining intensity and the intracellular 
localization of vinculin at 60 minutes, with no changes 
thereafter until 180 minutes. Nuclei are stained red. 
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Fig. 7. Measurements of the intensity of the fluorescent light in the microscope. The exposure time (in 
seconds) increases with ischemia; that is, the fluorescence intensity decreases. A, Actin; M myosin; TT, 
troponin T; TM, tropomyosin; Tb, tublin; D, desmin; Mm, myomesin; Vc, vinculin. 
uation and the intensity of the fluorescent light. 
Direct measurements of antibody fluorescence in- 
tensity offer significant advantages compared with 
quantitative determinations of antibody concentra- 
tion in tissue extracts by means of enzyme-linked 
immunoassay or Western blot techniques. In results 
obtained with both techniques, the composition of 
the tissue (the content of myocytes versus fibrous 
tissue) is unknown and a reference value for the 
measurements is therefore lacking. This problem is 
avoided with direct measurements in the microscope 
because the areas of interest can be identified. It is, 
howevei, necessary tostain and measure control and 
ischemic tissue simultaneously and to express all 
values with respect o control values. 
Effects of ischemia on contractile proteins. Actin, 
myosin, tropomyosin, and troponin T showed early 
alterations in antibody binding and significant de- 
creases in the intensity of fluorescence. To ex- 
clude the possibility that this rather unexpected 
finding was caused by the binding properties of 
one particular antibody, several antibodies against 
different epitopes of the same molecule were 
tested. These tests provided identical results. We 
therefore concluded that depolymerization of fil- 
aments was occurring during ischemia. This would 
explain the disturbed cross striation pattern in the 
presence of a persistent, if reduced, fluorescence 
intensity. 
The findings for actin presented here are in 
agreement with data published by Nishida, Hiruma, 
and Hashimoto, 13who found an early disappear, 
ance' of labeling for actin in regionally ischemic rat 
myocardium. Iwai and coworkers, 14on the other 
hand, noted a late distortion of actin labeling in the 
ischemic dog heart; this result corresponds with our 
pig and rabbit data (unpublished). 
In normal human myocardium, Hayakawa nd 
associates 15 used a polyclonal antibody against 
tropomyosin and observed slow disappearance of
staining for tropomyosin until 24 hours after death. 
This finding may not conflict with our results, be- 
cause Hayakawa nd associates 15 studied normal 
hearts. Normal hearts may behave similarly to that 
of normal animal myocardium. With the Western 
blot technique, however, Westfall and Solaro 16 
showed a decrease in tropomyosin i rat myocar- 
dium kept regionally ischemic for 60 minutes and 
reported the appearance of a band of lower molec- 
ular weight, suggestive of proteolysis. 
Ischemia of cytoskeletal proteins. Desmin, tubu- 
lin, and myomesin showed similar time courses of 
qualitative changes. Alterations of the intensity of 
fluorescence were minimal in the case of desmin and 
myomesin but were significant for tubulin. Ganote 
and Vander Heide 17 described desmin as more 
resistant o ischemia than vinculin, which is in 
contrast to ur findings. Differences in tissue pres- 
ervation and the use of different antibodies, how- 
ever, may have influenced the results. 
Studies describing the effects of ischemia on myo- 
mesin were not found in the literature, and there 
was only one report on tubulin organization in 
ischemia. Iwai and coworkers 14 found a time course 
of the disappearance of tubulin in canine myocar- 
dium similar to that in our study. Rupture and 
depolymerization f the microtubules were consid- 
ered to indicate irreversible cell injury. Our study 
does not confirm this view, however, because disap- 
pearance of tubulin was already observed uring the 
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Fig. 8. Western blotting of ischemic human myocardium with the different antibodies used in this study in 
control and at 30 and 120 minutes of ischemia. Protein fragments cannot be detected, but the bands 
become thinner with increasing time of ischemia. A, Actin; M, myosin; TT, troponin T; TM, tropomyosin; 
Tb, tublin; D, desmin; Mm, myomesin; Vc, vinculin. 
reversible stage of ischemic injury, as determined by 
electron microscopy. 
Vinculin in normal myocardium is found in the 
intercalated disks and at the costameres, confirming 
the localization pattern described earlier by Pardo, 
Siliciano, and Craig 18 and by Shear and Bloch. 19 
Steenbergen, Hill, and Jennings 2~ used polyclonal 
antibodies on totally ischemic dog myocardium and 
found an early disturbance of vinculin localization. 
This difference from the results presented here may 
have been caused by the use of different antibodies 
in the two studies. Ganote and Vander Heide 17 also 
found a drastic reduction of specific fluorescence for 
vinculin after 90 minutes of total ischemia, whereas 
Iwai and coworkers 14 showed an increased resistance 
of vinculin to ischemic damage. The increased tubulin 
fragility observed by this group is also in agreement 
with our findings. On the basis of our results, we 
believe that vinculin is more resistant o ischemic 
injury than are many other cardiac proteins and that 
this resistance is partially responsible for the mainte- 
nance of cellular structure during ischemia. 
Conclusion 
Depolymerization of filaments may be the first 
biochemical lesion of proteins in ischemia. This is 
indicated by the fact that the bands in the Western 
blot became thinner with progressing ischemia. We 
did not detect bands of lower molecular weight, 
which suggests either that smaller fragments were 
not abundant enough to be detected, or that the 
fragments did not carry the epitope and were there- 
fore nonreactive with the antibody. In addition, it is 
possible that in diseased human hearts depolymer- 
ization has already started and that proteolytic en- 
zymes are more abundant and possibly more active 
than in normal hearts. In ultrastructural studies of 
human hearts with dilated cardiomyopathy or ischemic 
heart disease, a significant increase of lysosomes has 
been shown. 21'22 Cytosoli c proteases may also in- 
crease. In ischemia, a drop in tissue pH may then 
activate these enzymes to produce protein degrada- 
tion. Because the antigenic epitopes may remain in- 
tact, the degradation fragments are still able to bind 
antibody and produce a certain fluorescence intensity. 
We conclude that ischemia in diseased human 
hearts causes important alterations of the cardiac 
contractile and cytoskeletal proteins. These alter- 
ations occur simultaneously with or frequently even 
precede ultrastructural ischemic injury. This severe 
damage may significantly influence the ability of the 
myocytes to recover Structural integrity and contrac- 
tile function during postischemic reperfusion. We 
therefore concluded that these alterations of con- 
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tractile and cytoskeletal proteins in addition to the 
damage to subcellular organelles play a decisive role 
in impeding the recovery of cardiac function after 
heart operations. 
The findings presented here were obtained in 
human hearts with either dilated cardiomyopathy or 
ischemic heart disease. In an earlier study with 
electron microscopy, we found that hypertrophic 
human hearts possess a lower threshold for ischemic 
injury than do hearts with ischemic heart disease. 23 
We therefore assume that these results apply to all 
types of patients undergoing heart operations and 
that care should be taken to avoid damage to 
structural proteins during induced cardiac arrest. 
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